ReviewCurrent HIV/AIDS reports2025
Addressing HIV and Substance Use Health Disparities among Racial/Ethnic Minority Individuals.
Review in Current HIV/AIDS reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- High Motivation but Low Access to PrEP: Social Determinants Undermine HIV Prevention Among Sexual and Gender Minority People Who Use Methamphetamine.AIDS and behavior · 2026Article
- Navigating sexual healthcare: a qualitative study on experiences, STI knowledge, and information sources among migrant men who have sex with men in the Netherlands.International journal for equity in health · 2026Article
- Patient and Service Provider Perspectives of Barriers and Facilitators to HIV Care in North Carolina.AIDS patient care and STDs · 2026Article
- DIFFICULTY ACCESSING SUBSTANCE USE TREATMENT AMONG INDIGENOUS PEOPLE IN A CANADIAN INNER CITY SETTING.International indigenous policy journal · 2026Article
- Patient pathways to PrEP persistence: a qualitative resilience-focused journey mapping study with cisgender Black and Latino men who have sex with men and clinical PrEP staff at a federally qualified health center.Frontiers in health services · 2026Article
- Barriers and pathways to re-engage people with HIV and substance use in medical care: a qualitative study among persons with lived experience.AIDS research and therapy · 2025Article
- Bon bagay (good stuff): A faith-based outlook on biomedical prevention among Haitians and Haitian Americans.PloS one · 2025Article
- Psychological and Clinical Risk Factors for Substance Use in People With and Without HIV.Journal of the International Association of Providers of AIDS CareArticle
- Racial Differences in Prenatal Cannabis Screening Among Women at Elevated Risk for Substance Use and Sexually Transmitted Infections.Journal of midwifery & women's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purpose of reviewAdvances in HIV testing, prevention, and treatment, alongside increased awareness and harm reduction efforts for substance use disorder (SUD) have improved care and treatment access over the past decade. However, racial and ethnic minorities with SUD and HIV or at risk for HIV still face disproportionately high health disparities. Understanding and addressing the reasons behind these disparities is crucial. RECENT
findingsStructural and systemic barriers continue to negatively impact minoritized communities, due to lack of access to care, mistrust, and feelings of ostracization. Disconnected systems for HIV and SUD treatment complicate combined care. Delays in HIV diagnosis and viral suppression reduce life expectancy for minority populations by around 10 years. Healthcare systems need to become more integrated, accessible, and culturally welcoming to marginalized communities. Promising interventions utilizing technology, harm reduction, and mobile service delivery can reduce barriers and improve outcomes for minority individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.